Arch Therapeutics, Inc.Arch Therapeutics, Inc.Arch Therapeutics, Inc.

Arch Therapeutics, Inc.

No trades
See on Supercharts

ARTH fundamentals

Arch Therapeutics, Inc. earnings per share and revenue

Estimated earnings per share for the next quarter are 82.00 USD, and revenue is expected to reach 123.94 M USD. Also watch annual changes over time to get a bigger picture of ARTH earnings per share and revenue dynamics.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise